Advertisement

Topics

#Biotech News: Cell MedX Corp. (OTCQB: $CMXC) Provides Update on its Clinical Observational Trial

02:00 EDT 31 Jul 2017 | InvestorIdeas

Carson City, Nevada - July 31, 2017 (Newsfile Corp.) (Investorideas.com Newswire) Cell MedX Corp. (OTCQB: CMXC), ("Cell MedX" or the "Company"), an early development stage bio-tech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness

Original Article: #Biotech News: Cell MedX Corp. (OTCQB: $CMXC) Provides Update on its Clinical Observational Trial

NEXT ARTICLE

More From BioPortfolio on "#Biotech News: Cell MedX Corp. (OTCQB: $CMXC) Provides Update on its Clinical Observational Trial"

Quick Search
Advertisement